Cell-assembled (Gd-DOTA)i-triphenylphosphonium (TPP) nanoclusters as a T2 contrast agent reveal in vivo fates of stem cell transplants
- 134 Downloads
A simple and straightforward strategy for magnetic resonance imaging (MRI) of stem cell transplants in terms of their viability, migration and homing, and differentiation has been pursued over the years. Herein we couple Gd-DOTA with triphenylphosphonium (TPP) to yield small molecule (Gd-DOTA)i-TPP (i = 1,4) agents and show that labeling cells with (Gd-DOTA)i-TPP via electroporation (EP) results in two distinct cellular distributions of (Gd-DOTA)i-TPP: freely and evenly distributed in the cytosol or cell-assembled nanoclusters in the cytoplasm. The two distinct cellular distributions contribute in different ways to MRI signals in vitro and in vivo. Importantly, we present a detailed interpretation of MRI results based on the signal intensity equation and cellular longitudinal (T1-) and transverse (T2-) relaxation rates of water protons. We demonstrate that cell-assembled (Gd-DOTA)i-TPP nanoclusters not only promote its intracellular retention time but also induce significant MRI signal reduction, which act as an excellent T2 contrast agent and allows for unambiguous reporting of in vivo viability and migration of cell transplants under T2-weighted MRI over a long period. Notably, (Gd-DOTA)i-TPP agents released as a result of exocytosis or cell death induce signal enhancement in the surrounding tissue such that the labeled cells can be unambiguously discriminated from its host tissue. The labeling and imaging strategy provides abundant information on the in vivo fates of stem cell transplants. The strategy features a single contrast, single imaging mode with dual signal output.
Keywordsmagnetic resonance imaging (MRI) GDL contrast agent cell transplantation stem cells cell viability
Unable to display preview. Download preview PDF.
This work was funded by general projects from the National Natural Science Foundation of China (Nos. 21673281, 31371010), a Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDA01030203), and a Basic Research Project from the Ministry of Science and Technology of China (No. 2011CB965004). The authors also acknowledge Karebay Biochem Inc. for assistance with synthesis of DOTAi-TPP.
- Kraitchman, D. L.; Bulte, J. W. M. Imaging of stem cells using MRI. Basic Res. Cardiol. 2008, 103, 105–113.Google Scholar
- Mahmoudi, M.; Hosseinkhani, H.; Hosseinkhani, M.; Boutry, S.; Simchi, A.; Shane Journeay, W.; Subramani, K.; Laurent, S. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem. Rev. 2011, 111, 253–280.CrossRefGoogle Scholar
- Bulte, J. W. M.; Zhang, S. C.; van Gelderen, P.; Herynek, V.; Jordan, E. K.; Duncan, I. D.; Frank, J. A. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 1999, 96, 15256–15261.CrossRefGoogle Scholar
- Hoehn, M.; Kü stermann, E.; Blunk, J.; Wiedermann, D.; Trapp, T.; Wecker, S.; Fö cking, M.; Arnold, H.; Hescheler, J.; Fleischmann, B. K. et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 2002, 99, 16267–16272.CrossRefGoogle Scholar
- Hinds, K. A.; Hill, J. M.; Shapiro, E. M.; Laukkanen, M. O.; Silva, A. C.; Combs, C. A.; Varney, T. R.; Balaban, R. S.; Koretsky, A. P.; Dunbar, C. E. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003, 102, 867–872.CrossRefGoogle Scholar
- Terrovitis, J.; Stuber, M.; Youssef, A.; Preece, S.; Leppo, M.; Kizana, E.; Schä r, M.; Gerstenblith, G.; Weiss, R. G.; Marbá n, E. et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008, 117, 1555–1562.CrossRefGoogle Scholar
- Khurana, A.; Nejadnik, H.; Gawande, R.; Lin, G. T.; Lee, S. M.; Messing, S.; Castaneda, R.; Derugin, N.; Pisani, L.; Lue, T. F. et al. Intravenous ferumoxytol allows noninvasive MRimaging monitoring of macrophage migration into stem cell transplants. Radiology 2012, 264, 803–811.CrossRefGoogle Scholar
- Guenoun, J.; Ruggiero, A.; Doeswijk, G.; Janssens, R. C.; Koning, G. A.; Kotek, G.; Krestin, G. P.; Bernsen, M. R. In vivo quantitative assessement of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging. Contrast Media Mol. Imaging 2013, 8, 165–174.CrossRefGoogle Scholar
- Nejadnik, H.; Ye, D. J.; Lenkov, O. D.; Doing, J. S.; Martin, J. E; Castillo, R.; Derugin, N.; Sennino, B.; Rao, J. H.; Daldrup-Link, H. E. Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent. ACS Nano 2015, 9, 1150–1160.CrossRefGoogle Scholar
- McRobbie, D. W; Moore, E. A.; Graves, M. J.; Prince, M. R. MRI from Picture to Proton; 2nd ed. Cambridge University Press: New York, 2007.Google Scholar
- Digilio. G.; Catanzaro, V.; Fedeli, F.; Gianolio, E.; Menchise, V.; Napolitano, R.; Gringeri, C.; Aime, S. Targeting exofacial protein thiols with GdIII complexes. An efficient procedure for MRI cell labelling. Chem. Comm. 2009, 893–895.Google Scholar
- Wang, L. R.; Lin, H. Y.; Ma, L. C.; Jin, J. B.; Shen, T. P.; Wei, R. X.; Wang, X. M.; Ai, H.; Chen, Z.; Gao, J. H. Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T 1-T 2 dual-mode contrast agents for accurate liver tumor imaging. Nanoscale 2017, 9, 4516–4523.CrossRefGoogle Scholar